SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POSASR - Post-effective Amendment to an automatic shelf registration statement:
SEC Accession No. 0001193125-20-007892
Filing Date
2020-01-15
Accepted
2020-01-15 12:56:47
Documents
1
Effectiveness Date
2020-01-15

Document Format Files

Seq Description Document Type Size
1 POSASR d869969dposasr.htm POSASR 18261
  Complete submission text file 0001193125-20-007892.txt   19286
Mailing Address 600 CALIFORNIA ST., 17TH FLOOR SAN FRANCISCO CA 94108
Business Address 600 CALIFORNIA ST., 17TH FLOOR SAN FRANCISCO CA 94108 415-638-6556
Audentes Therapeutics, Inc. (Filer) CIK: 0001628738 (see all company filings)

IRS No.: 461606174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POSASR | Act: 33 | File No.: 333-224020 | Film No.: 20527878
SIC: 2836 Biological Products, (No Diagnostic Substances)